Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LTRNLantern Pharma Inc.

Nasdaq · CIK 0001763950
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts287

Identity from submissions API

NameLantern Pharma Inc.
CIK0001763950
TickersLTRN
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN463973463
LEI—
Fiscal year end1231
State of incorporationTX TX
Phone972-277-1136
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Lantern Pharma (2019-01-14T00:00:00.000Z → 2019-01-14T00:00:00.000Z)
Business address
1920 MCKINNEY AVENUE
7TH FLOOR
DALLAS
TX
75201
TX
Mailing address
1920 MCKINNEY AVENUE
7TH FLOOR
DALLAS
TX
75201
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

267 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 DEFA14A DEFA14A 0001493152-26-053480 001-39318 261579211 34 25807
2026-11-18 8-K 8-K 2.02,9.01 0001493152-26-052991 001-39318 261568034 34 285825 1 1
2026-11-17 10-Q 10-Q 0001493152-26-052848 001-39318 261566451 34 5791468 1 1
2026-11-17 NT 10-Q NT 10-Q 0001493152-26-052845 001-39318 261566384 34 33835
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005243 005-91536 261558045 34 10454
2026-10-21 ARS ARS 0001493152-26-047808 001-39318 261473902 34 2877009
2026-10-19 DEF 14A DEF 14A 0001493152-26-047586 001-39318 261469204 34 2997206 1 1
2026-10-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-006874 005-91536 261456126 34 12615
2026-10-08 PRE 14A PRE 14A 0001493152-26-046325 001-39318 261449970 34 3488464 1 1
2026-10-01 8-K 8-K 3.01 0001493152-26-045344 001-39318 261431234 34 200506 1 1
2026-09-30 8-K 8-K 1.01,3.02,9.01 0001493152-26-045100 001-39318 261427186 34 1034528 1 1
2026-09-30 424B5 424B5 0001493152-26-045049 333-279718 261425724 33 591031
2026-09-24 8-K 8-K 7.01,9.01 0001493152-26-044007 001-39318 261401976 34 11692103 1 1
2026-09-23 8-K 8-K 7.01,9.01 0001493152-26-043808 001-39318 261398197 34 255488 1 1
2026-08-14 8-K 8-K 2.02,7.01,9.01 0001493152-26-037979 001-39318 261276097 34 8307792 1 1
2026-08-14 10-Q 10-Q 0001493152-26-037971 001-39318 261276083 34 5293214 1 1
2026-08-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004747 005-91536 261236154 34 15833
2026-08-03 8-K 8-K 7.01,9.01 0001493152-26-035864 001-39318 261234581 34 380289 1 1
2026-07-23 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-086180 005-91536 261196467 34 8110
2026-06-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002072 333-296752 261104730 33 1835
2026-06-12 S-1 S-1 0001493152-26-028460 333-296752 261087263 33 528188 1 1
2026-06-02 8-K 8-K 7.01,9.01 0001493152-26-026696 001-39318 261053147 34 8624963 1 1
2026-05-21 D xslFormDX01/primary_doc.xml 06b 0001493152-26-024786 021-584796 261007855 33 11842
2026-05-15 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001813314-26-000008 005-91536 26988022 34 39424
2026-05-15 8-K 8-K 2.02,9.01 0001493152-26-023758 001-39318 26987225 34 296725 1 1
2026-05-15 10-Q 10-Q 0001493152-26-023740 001-39318 26987048 34 3548760 1 1
2026-05-14 8-K 8-K 1.01,3.02,8.01,9.01 0001493152-26-023200 001-39318 26980606 34 1087638 1 1
2026-05-14 4 4 0001493152-26-023083 7274
2026-05-14 4 4 0001493152-26-023082 7258
2026-05-14 424B5 424B5 0001493152-26-022895 333-279718 26976123 33 533712
2026-04-30 10-K/A 10-K/A 0001493152-26-019713 001-39318 26919749 34 543608 1 1
2026-04-16 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001813314-26-000005 005-91536 26867319 34 35451
2026-04-10 8-K 8-K 7.01,9.01 0001493152-26-016047 001-39318 26853211 34 3291792 1 1
2026-04-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-039486 005-91536 26837125 34 7993
2026-03-30 424B5 424B5 0001493152-26-013685 333-279718 26814582 33 478532
2026-03-30 10-K 10-K 0001493152-26-013612 001-39318 26813682 34 10878798 1 1
2026-03-30 8-K 8-K 2.02,7.01,9.01 0001493152-26-013608 001-39318 26813670 34 5504802 1 1
2026-02-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001813314-26-000002 005-91536 26665870 34 37640
2026-01-23 8-K 8-K 7.01,9.01 0001493152-26-003314 001-39318 26553338 34 16266310 1 1
2026-01-13 4 4 0001493152-26-002024 7931
2026-01-13 4 4 0001493152-26-002025 7932
2026-01-13 4 4 0001493152-26-002023 7909
2026-01-13 4 4 0001493152-26-002026 7950
2026-01-13 4 4 0001493152-26-002027 7930
2025-12-22 4 4 0001493152-25-028759 5547
2025-12-22 4 xslF345X05/ownership.xml 0001493152-25-028758 5620
2025-11-13 8-K 8-K 2.02,7.01,9.01 0001493152-25-022134 001-39318 251475599 34 8453211 1 1
2025-11-12 10-Q 10-Q 0001493152-25-021927 001-39318 251473004 34 4118052 1 1
2025-09-23 8-K 8-K 5.07 0001493152-25-014652 001-39318 251334267 34 215345 1 1
2025-09-23 4 4 0001493152-25-014617 12598
2025-09-23 4 4 0001493152-25-014616 8059
2025-09-23 4 4 0001493152-25-014615 12905
2025-09-23 4 4 0001493152-25-014614 12620
2025-09-23 4 4 0001493152-25-014612 12817
2025-09-23 4 4 0001493152-25-014611 12619
2025-08-20 4 4 0001641172-25-025000 5554
2025-08-13 8-K 8-K 2.02,9.01 0001641172-25-023489 001-39318 251211851 34 333177 1 1
2025-08-13 10-Q 10-Q 0001641172-25-023471 001-39318 251211574 34 3705900 1 1
2025-08-11 ARS formars.pdf 0001641172-25-022896 001-39318 251200142 34 2450951
2025-08-08 DEF 14A DEF 14A 0001641172-25-022820 001-39318 251199451 34 7488584 1 1
2025-07-30 3 xslF345X02/ownership.xml 0001641172-25-021588 3021
2025-07-29 8-K 8-K 5.02,5.03,9.01 0001641172-25-021407 001-39318 251162845 34 218364 1 1
2025-07-28 PRE 14A PRE 14A 0001641172-25-021186 001-39318 251156618 34 7487695 1 1
2025-07-03 8-K 8-K 1.01,9.01 0001641172-25-017810 001-39318 251105656 34 601042 1 1
2025-07-03 424B5 424B5 0001641172-25-017790 333-279718 251105576 33 446782
2025-06-13 4 OWNERSHIP DOCUMENT 0001104659-25-059528 32581
2025-06-13 4 OWNERSHIP DOCUMENT 0001104659-25-059526 21357
2025-06-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-059524 005-91536 251048142 34 35647
2025-06-13 4 OWNERSHIP DOCUMENT 0001104659-25-059106 49903
2025-06-13 4 OWNERSHIP DOCUMENT 0001104659-25-059091 38675
2025-05-29 4 OWNERSHIP DOCUMENT 0001104659-25-054422 136409
2025-05-29 4 OWNERSHIP DOCUMENT 0001104659-25-054421 102580
2025-05-27 144 xsl144X01/primary_doc.xml 0001104659-25-053175 001-39318 25990663 33 4577
2025-05-27 144 xsl144X01/primary_doc.xml 0001104659-25-053174 001-39318 25990661 33 4558
2025-05-27 144 xsl144X01/primary_doc.xml 0001104659-25-053172 001-39318 25990659 33 4560
2025-05-27 144 xsl144X01/primary_doc.xml 0001104659-25-053171 001-39318 25990658 33 4574
2025-05-27 144 xsl144X01/primary_doc.xml 0001104659-25-053170 001-39318 25990657 33 4587
2025-05-15 10-Q 10-Q 0001641172-25-010547 001-39318 25948945 34 3420310 1 1
2025-05-15 8-K 8-K 2.02,7.01,9.01 0001641172-25-010541 001-39318 25948924 34 13603760 1 1
2025-04-30 10-K/A form10-ka.htm 0001641172-25-006728 001-39318 25890472 34 832990 1 1
2025-03-27 10-K form10-k.htm 0001641172-25-000926 001-39318 25779282 34 9688682 1 1
2025-03-27 8-K form8-k.htm 2.02,7.01,9.01 0001641172-25-000917 001-39318 25779224 34 17152148 1 1
2025-01-10 8-K form8-k.htm 5.02 0001493152-25-001685 001-39318 25522886 34 211305 1 1
2024-11-08 8-K form8-k.htm 7.01,9.01 0001493152-24-044124 001-39318 241437734 34 11508339 1 1
2024-11-07 10-Q form10-q.htm 0001493152-24-044010 001-39318 241435601 34 3936825 1 1
2024-11-07 8-K form8-k.htm 2.02,9.01 0001493152-24-044006 001-39318 241435520 34 333164 1 1
2024-08-08 10-Q form10-q.htm 0001493152-24-030766 001-39318 241188296 34 3799110 1 1
2024-08-08 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-030764 001-39318 241188262 34 32378114 1 1
2024-07-26 4 xslF345X05/ownership.xml 0001493152-24-029238 7040
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028187 5507
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028185 5522
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028184 5530
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028186 5538
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028183 7894
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028182 5626
2024-07-17 4 xslF345X05/ownership.xml 0001493152-24-028188 7915
2024-06-17 8-K form8-k.htm 5.07 0001493152-24-024110 001-39318 241048406 34 222742 1 1
2024-06-10 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-10 16:30:00 9999999995-24-001803 333-279718 241034540 33 1842
2024-06-06 CORRESP filename1.htm 0001493152-24-022884 19814
2024-06-03 UPLOAD filename1.pdf 0000000000-24-006316 333-279718 40351
2024-05-28 4 OWNERSHIP DOCUMENT 0001104659-24-065619 25078
2024-05-28 4 OWNERSHIP DOCUMENT 0001104659-24-065616 36383
2024-05-24 8-K form8-k.htm 5.03,9.01 0001493152-24-021353 001-39318 24984364 34 222072 1 1
2024-05-24 S-8 forms-8.htm 0001493152-24-021351 333-279723 24984331 33 122461
2024-05-24 S-3 forms-3.htm 0001493152-24-021347 333-279718 24984290 33 1499808
2024-05-09 10-Q form10-q.htm 0001493152-24-018422 001-39318 24930455 34 3462620 1 1
2024-05-09 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-018426 001-39318 24930451 34 9090859 1 1
2024-05-03 ARS ars.pdf 0001493152-24-017626 001-39318 24910794 34 2998443
2024-04-29 DEF 14A formdef14a.htm 0001493152-24-016840 001-39318 24886599 34 924801
2024-04-26 144 xsl144X01/primary_doc.xml 0001104659-24-053232 001-39318 24886253 33 9994
2024-04-26 144 xsl144X01/primary_doc.xml 0001104659-24-053231 001-39318 24886252 33 10021
2024-04-26 144 xsl144X01/primary_doc.xml 0001104659-24-053230 001-39318 24886251 33 10010
2024-04-26 144 xsl144X01/primary_doc.xml 0001104659-24-053229 001-39318 24886246 33 9994
2024-04-26 144 xsl144X01/primary_doc.xml 0001104659-24-053228 001-39318 24886245 33 10009
2024-03-18 10-K form10-k.htm 0001493152-24-010302 001-39318 24759007 34 9303195 1 1
2024-03-18 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-010303 001-39318 24759000 34 8420608 1 1
2024-03-01 SC 13D/A SC 13D/A 0001104659-24-029971 005-91536 24709781 34 319429
2024-02-29 4 OWNERSHIP DOCUMENT 0001104659-24-029534 41761
2024-02-29 4 OWNERSHIP DOCUMENT 0001104659-24-029533 30685
2024-02-28 144 xsl144X01/primary_doc.xml 0001104659-24-028950 001-39318 24698504 33 5209
2024-02-28 144 xsl144X01/primary_doc.xml 0001104659-24-028949 001-39318 24698501 33 5252
2024-02-28 144 xsl144X01/primary_doc.xml 0001104659-24-028948 001-39318 24698499 33 5231
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006658 005-91536 24637824 34 48301
2024-01-19 4 OWNERSHIP DOCUMENT 0001104659-24-005242 43148
2024-01-19 4 OWNERSHIP DOCUMENT 0001104659-24-005238 31848
2023-12-29 8-K form8-k.htm 5.02 0001493152-23-046572 001-39318 231527681 34 210600 1 1
2023-12-01 SC 13D/A SC 13D/A 0001104659-23-122546 005-91536 231457438 34 321496
2023-12-01 4 OWNERSHIP DOCUMENT 0001104659-23-122540 70343
2023-12-01 4 OWNERSHIP DOCUMENT 0001104659-23-122539 59695
2023-11-24 8-K form8-k.htm 1.01 0001493152-23-042670 001-39318 231436783 34 208247 1 1
2023-11-08 10-Q form10-q.htm 0001493152-23-039896 001-39318 231387765 34 4025805 1 1
2023-11-08 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-039900 001-39318 231387762 34 9941234 1 1
2023-10-20 8-K form8-k.htm 8.01 0001493152-23-037907 001-39318 231337813 34 209369 1 1
2023-08-09 10-Q form10-q.htm 0001493152-23-027345 001-39318 231155100 34 4330846 1 1
2023-08-09 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-027346 001-39318 231155093 34 6362952 1 1
2023-06-21 8-K form8-k.htm 5.07 0001493152-23-022001 001-39318 231029818 34 227150 1 1
2023-05-09 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-015941 001-39318 23901901 34 8685338 1 1
2023-05-09 10-Q form10-q.htm 0001493152-23-015940 001-39318 23901894 34 3524023 1 1
2023-05-05 ARS formars.pdf 0001493152-23-015519 001-39318 23891617 34 2154321
2023-04-28 DEF 14A formdef14a.htm 0001493152-23-013927 001-39318 23859527 34 971897
2023-03-20 10-K form10-k.htm 0001493152-23-008241 001-39318 23746428 34 10847698 1 1
2023-03-20 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-008242 001-39318 23746421 34 9812893 1 1
2023-01-18 8-K form8-k.htm 5.02 0001493152-23-001789 001-39318 23534775 34 209122 1 1
2022-11-21 SC 13G formsc13g.htm 0001493152-22-033103 005-91536 221405913 34 47866
2022-11-09 4 OWNERSHIP DOCUMENT 0001104659-22-116667 19302
2022-11-09 4 OWNERSHIP DOCUMENT 0001104659-22-116666 31100
2022-11-07 10-Q form10-q.htm 0001493152-22-030819 001-39318 221365404 34 4232015 1 1
2022-11-07 8-K form8-k.htm 2.02,7.01,9.01 0001493152-22-030817 001-39318 221365400 34 2673476 1 1
2022-10-24 4 xslF345X03/ownership.xml 0001493152-22-029456 5463
2022-09-07 4 OWNERSHIP DOCUMENT 0001104659-22-098246 38432
2022-09-07 4 OWNERSHIP DOCUMENT 0001104659-22-098245 27450
2022-08-09 4 OWNERSHIP DOCUMENT 0001213900-22-045909 5558
2022-08-08 10-Q form10-q.htm 0001493152-22-021610 001-39318 221144338 34 3843837 1 1
2022-08-08 8-K form8-k.htm 2.02,7.01,9.01 0001493152-22-021614 001-39318 221144331 34 9398273 1 1
2022-06-17 3 xslF345X02/ownership.xml 0001213900-22-033590 2921
2022-06-14 8-K CURRENT REPORT 5.07 0001213900-22-032619 001-39318 221013418 34 218077 1 1
2022-05-03 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-22-023730 001-39318 22888540 34 3985584
2022-05-03 10-Q QUARTERLY REPORT 0001213900-22-023583 001-39318 22886717 34 3338071 1 1
2022-05-03 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-22-023584 001-39318 22886714 34 4205376 1 1
2022-04-27 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-22-021955 001-39318 22860482 34 579516
2022-04-26 8-K CURRENT REPORT 5.02,7.01,9.01 0001213900-22-021526 001-39318 22851744 34 246038 1 1
2022-04-25 8-K CURRENT REPORT 8.01 0001213900-22-021397 001-39318 22849721 34 201650 1 1
2022-03-22 SC 13D/A SC 13D/A 0001104659-22-036569 005-91536 22759680 34 322287
2022-03-22 8-K CURRENT REPORT 8.01,9.01 0001213900-22-013992 001-39318 22757164 34 223929 1 1
2022-03-21 4 PRIMARY DOCUMENT 0001813316-22-000001 30030
2022-03-10 10-K ANNUAL REPORT 0001213900-22-011581 001-39318 22729103 34 6492784 1 1
2022-03-10 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-22-011579 001-39318 22729070 34 7154003 1 1
2022-01-24 8-K CURRENT REPORT 8.01,9.01 0001213900-22-003180 001-39318 22547528 34 233865 1 1
2022-01-11 SC 13G/A LANTERN PHARMA INC. 0000902664-22-000157 005-91536 22523021 34 76597
2021-11-22 8-K CURRENT REPORT 8.01,9.01 0001213900-21-061032 001-39318 211430315 34 224021 1 1
2021-11-08 4 PRIMARY DOCUMENT 0001813316-21-000002 23388
2021-11-08 4 xslF345X03/ownership.xml 0001213900-21-057327 5313
2021-11-08 4 xslF345X03/ownership.xml 0001213900-21-057324 5393
2021-11-08 4 xslF345X03/ownership.xml 0001213900-21-057326 5414
2021-11-08 4 xslF345X03/ownership.xml 0001213900-21-057325 5423
2021-11-02 4 xslF345X03/ownership.xml 0001213900-21-056109 5520
2021-11-02 4 xslF345X03/ownership.xml 0001213900-21-056108 5432
2021-11-01 10-Q QUARTERLY REPORT 0001213900-21-055780 001-39318 211367168 34 3816794 1 1
2021-11-01 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-21-055781 001-39318 211367159 34 5596679 1 1
2021-07-29 10-Q QUARTERLY REPORT 0001213900-21-039286 001-39318 211127341 34 4188575 1 1
2021-07-29 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-21-039285 001-39318 211127309 34 5360347
2021-07-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-07-12 17:00:00 9999999995-21-002727 333-257643 211086747 33 1793
2021-07-08 CORRESP filename1.htm 0001213900-21-036182 18086
2021-07-07 UPLOAD filename1.pdf 0000000000-21-008376 40209
2021-07-02 S-3 REGISTRATION STATEMENT 0001213900-21-035559 333-257643 211070227 33 1172346
2021-05-25 8-K CURRENT REPORT 5.07 0001213900-21-028984 001-39318 21958749 34 37806
2021-05-03 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-21-024233 001-39318 21883678 34 4420306
2021-05-03 10-Q QUARTERLY REPORT 0001213900-21-024222 001-39318 21883452 34 1776182 1
2021-04-09 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-21-020953 001-39318 21816960 34 431376
2021-04-09 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-020952 001-39318 21816954 34 2060702
2021-03-10 10-K ANNUAL REPORT 0001213900-21-014576 001-39318 21729737 34 7256935 1
2021-03-10 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-21-014567 001-39318 21729654 34 4839170
2021-02-16 SC 13G SC 13G 0001193125-21-044827 005-91536 21637897 34 215321
2021-02-16 SC 13G SC 13G 0001104659-21-023530 005-91536 21635414 34 38572
2021-01-25 SC 13G LANTERN PHARMA INC. 0000902664-21-000498 005-91536 21548225 34 80095
2021-01-19 4 FORM 4 SUBMISSION 0000899243-21-002387 17911
2021-01-15 424B4 PROSPECTUS SUPPLEMENT 0001213900-21-002604 333-251992 21533117 33 16136786
2021-01-15 S-1MEF REGISTRATION STATEMENT 0001213900-21-002378 333-252116 21530451 33 48416
2021-01-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-01-14 17:00:00 9999999995-21-000165 333-251992 21530435 33 1792
2021-01-11 CORRESP filename1.htm 0001213900-21-001391 6207
2021-01-11 FWP FREE WRITING PROSPECTUSES 0001213900-21-001294 333-251992 21518999 34 15933702
2021-01-08 CORRESP filename1.htm 0001213900-21-001249 11598
2021-01-08 S-1 REGISTRATION STATEMENT 0001213900-21-001239 333-251992 21518282 33 20950761
2021-01-06 8-K CURRENT REPORT 1.01,8.01 0001213900-21-000653 001-39318 21510335 34 29940
2020-12-21 UPLOAD filename1.pdf 0000000000-20-012252 40510
2020-12-16 DRS filename1.htm 0001213900-20-042883 377-03896 201391217 33 25896657
2020-12-15 DRSLTR filename1.htm 0001213900-20-042885 7328
2020-10-29 10-Q QUARTERLY REPORT 0001213900-20-033954 001-39318 201272568 34 2523052 1
2020-10-29 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-20-033953 001-39318 201272563 34 8219911
2020-08-21 8-K CURRENT REPORT 5.02,9.01 0001213900-20-023177 001-39318 201121428 34 149069
2020-07-30 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-20-019152 001-39318 201059064 34 3563294
2020-07-30 10-Q QUARTERLY REPORT 0001213900-20-019151 001-39318 201059063 34 1920732 1
2020-07-16 8-K CURRENT REPORT 1.01 0001213900-20-017658 001-39318 201031650 34 26205
2020-06-23 SC 13D SC 13D 0001193125-20-176446 005-91536 20981756 34 610651
2020-06-23 SC 13D SCHEDULE 13D 0001213900-20-015494 005-91536 20979769 34 126329
2020-06-19 SC 13D SCHEDULE 13D 0001213900-20-015351 005-91536 20975659 34 86708
2020-06-17 4 FORM 4 SUBMISSION 0000899243-20-016898 31494
2020-06-17 8-K CURRENT REPORT 3.02,5.03,8.01,9.01 0001213900-20-015132 001-39318 20967697 34 3231595
2020-06-16 4 PRIMARY DOCUMENT 0001789490-20-000005 48329
2020-06-16 4 PRIMARY DOCUMENT 0001813316-20-000002 37392
2020-06-16 SEC STAFF LETTER filename1.pdf 9999999997-20-003633 271968
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015052 5717
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015051 6132
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015050 6245
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015049 5633
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015048 5700
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015047 6151
2020-06-15 4 xslF345X03/ownership.xml 0001213900-20-015046 2941
2020-06-15 4 OWNERSHIP DOCUMENT 0001213900-20-015034 10272
2020-06-15 4 OWNERSHIP DOCUMENT 0001213900-20-015029 5031
2020-06-12 424B4 PROSPECTUS 0001213900-20-014754 333-237714 20958874 33 18178361
2020-06-12 S-1MEF REGISTRATION STATEMENT 0001213900-20-014750 333-239112 20958841 33 95612
2020-06-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-06-10 17:00:00 9999999995-20-001384 333-237714 20956109 33 1792
2020-06-10 3 PRIMARY DOCUMENT 0001789490-20-000004 43439
2020-06-10 3 PRIMARY DOCUMENT 0001813316-20-000001 32925
2020-06-10 3 FORM 3 SUBMISSION 0000899243-20-015994 26544
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014637 2959
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014635 4841
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014633 3082
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014630 2876
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014626 6152
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014623 2988
2020-06-10 3 OWNERSHIP DOCUMENT 0001213900-20-014619 7632
2020-06-10 3 xslF345X02/ownership.xml 0001213900-20-014617 4073
2020-06-10 3 xslF345X02/ownership.xml 0001213900-20-014615 5551
2020-06-08 CERT 8A CERT 0001354457-20-000234 001-39318 20949124 34 86962
2020-06-08 CORRESP filename1.htm 0001213900-20-014363 11589
2020-06-08 CORRESP filename1.htm 0001213900-20-014360 18893
2020-06-08 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-20-014353 001-39318 20948323 34 15609
2020-06-08 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-20-014351 333-237714 20948321 33 148603
2020-06-02 CORRESP filename1.htm 0001213900-20-013930 22938
2020-05-29 UPLOAD filename1.pdf 0000000000-20-004788 43041
2020-05-22 CORRESP filename1.htm 0001213900-20-013341 48271
2020-05-22 UPLOAD filename1.pdf 0000000000-20-004571 43267
2020-05-19 FWP FREE WRITING PROSPECTUS 0001213900-20-012890 333-237714 20892178 34 19536702
2020-05-19 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-20-012863 333-237714 20891344 33 10001341
2020-05-12 CORRESP filename1.htm 0001213900-20-011749 59507
2020-05-12 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-20-011747 333-237714 20866954 33 10296235
2020-05-01 UPLOAD filename1.pdf 0000000000-20-003726 52042
2020-04-16 CORRESP filename1.htm 0001213900-20-009333 97784
2020-04-16 S-1 REGISTRATION STATEMENT 0001213900-20-009332 333-237714 20796183 33 6664250
2020-02-21 SEC STAFF LETTER filename1.pdf 9999999997-20-000979 230521
2020-02-21 UPLOAD filename1.pdf 0000000000-20-001618 63147
2020-01-24 DRSLTR filename1.htm 0001213900-20-001733 28125
2020-01-24 DRS filename1.htm 0001213900-20-001732 377-03009 20545211 33 28793629
2019-03-18 D xslFormDX01/primary_doc.xml 06b 0001763950-19-000004 021-335101 19688472 33 9577
2019-01-14 D xslFormDX01/primary_doc.xml 06b 0001763950-19-000001 021-330392 19524317 33 8970

Latest XBRL company facts

One latest value per concept from companyfacts (287 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 15.89M 2026-11-09 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
dei EntityPublicFloat Entity Public Float USD 33.94M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001493152-26-019713
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 417,045 2025-01-01 2025-12-31 DEF 14A 2026-10-19 0001493152-26-047586
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 415,002 2025-01-01 2025-12-31 DEF 14A 2026-10-19 0001493152-26-047586
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 778,962 2025-01-01 2025-12-31 DEF 14A 2026-10-19 0001493152-26-047586
ecd PeoTotalCompAmt PeoTotalCompAmt USD 763,750 2025-01-01 2025-12-31 DEF 14A 2026-10-19 0001493152-26-047586
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 70.79 2025-01-01 2025-12-31 DEF 14A 2026-10-19 0001493152-26-047586
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 5.61M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 664,533 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 102,831 2020-06-30 2020 Q2 10-Q 2020-07-30 0001213900-20-019151
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 108,500 2020-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -46,053 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 104.30M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 36,000 2020-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 38,800 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 229,550 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023740
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 30,722 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap Assets Assets USD 8.52M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AssetsCurrent Assets, Current USD 8.41M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 4,483 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010302
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 564,960 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010302
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 19.93M 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010302
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 5.23M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value USD 283,056 2023-03-31 2023 Q1 10-Q 2023-05-09 0001493152-23-015940
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 14.42M 2024-03-31 2024 Q1 10-Q 2024-05-09 0001493152-24-018422
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 2.72M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap Cash Cash USD 2.38M 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023740
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.62M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 33.30M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 47.19M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 7.62M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 36.44M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-01 0001213900-21-055780
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 6.64M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3.13 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030819
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 79,021 2024-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023471
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.49M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap CommonStockDividendsShares Common Stock Dividends, Shares shares 40,727 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 14.94M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 14.94M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,494 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -9.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 13.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap CostOfGoodsAndServicesSoldAmortization Cost, Amortization USD 13.26M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-01 0001213900-21-055780
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 66,000 2020-01-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 109,000 2021-12-31 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.01 2020-04-29 2020-05-01 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 13.20M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030819
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 2,550 2024-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 4.62M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030819
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 64 2024-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 22,289 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD 108,486 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001493152-24-044010
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 17,686 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 18,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 21.76M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.72M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3,626 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 16.09M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 75.60M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 1.00M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 600,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Deferred Tax Assets, Tax Credit Carryforwards, General Business USD 3.10M 2020-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 274,000 2023-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010302
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.70M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 624,182 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 22,624 2023-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 21.75M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 6,237 2020-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2,566 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 438 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 101,205 2020-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 11,086 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 8,319 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030766
us-gaap DerivativeCostOfHedge Derivative, Cost of Hedge USD 658,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.13 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.233 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.04 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.01 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.04 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 16,313 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 262,915 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023740
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 716,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap EquitySecuritiesFvNiRealizedLoss Equity Securities, FV-NI, Realized Loss USD 84,378 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap EscrowDepositsRelatedToPropertySales Escrow Deposits Related to Property Sales USD 459,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 25.00M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 11.09M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap ExcessStockSharesOutstanding Excess Stock, Shares Outstanding shares 11.09M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -3.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 86,805 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 2.81M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Held-to-Maturity, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 4.46M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 12.82M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 16.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 139,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -3.98M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD -110,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -493,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -169,049 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 49,325 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -58,515 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -10,648 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 101,283 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 984,463 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 1.03M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap InsuranceCommissionsAndFees Insurance Commissions and Fees USD 1.26M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-29 0001213900-20-033954
us-gaap InterestIncomeOther Interest Income, Other USD 98,920 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap InterestReceivable Interest Receivable USD 5,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 81,870 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 20,326 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 0.8 2020-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 366,900 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap LeaseCost Lease, Cost USD 125,800 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 49,050 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 28,800 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 54,744 2024-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 20,250 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1,776 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap Liabilities Liabilities USD 7.11M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 8.52M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LiabilitiesCurrent Liabilities, Current USD 5.65M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 108,500 2020-06-30 2020 Q2 10-Q 2020-07-30 0001213900-20-019151
us-gaap ManufacturingCosts Manufacturing Costs USD 804,403 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023740
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 10,882 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 13.15M 2021-09-30 2021 Q3 10-Q 2021-11-01 0001213900-21-055780
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 76,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030819
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 7.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 5.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -10.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -9.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 4.12M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -9.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -13.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 4.07M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OperatingExpenses Operating Expenses USD 12.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -12.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeaseCost Operating Lease, Cost USD 58,700 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 47,274 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 40,169 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 7,105 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeasePayments Operating Lease, Payments USD 61,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 46,538 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 56,307 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 53,403 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 119,705 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 173,108 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 38,698 2021-09-30 2021 Q3 10-Q 2021-11-01 0001213900-21-055780
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.077 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherAccountsPayableAndAccruedLiabilities Other Accounts Payable and Accrued Liabilities USD 240,000 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap OtherAssetsCurrent Other Assets, Current USD 65,000 2020-09-30 2020 Q3 10-Q 2020-10-29 0001213900-20-033954
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 26,090 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD -218,780 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -69,279 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -71,483 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2,204 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherExpenses Other Expenses USD 1.86M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 42,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-09 0001493152-23-015940
us-gaap OtherNoncashExpense Other Noncash Expense USD 56,307 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 51,998 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.45M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 24,215 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap OwnshareLendingArrangementSharesIssued Own-share Lending Arrangement, Shares, Issued shares 800 2021-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap PartnersCapitalAccountUnitsSoldInPublicOffering Partners' Capital Account, Units, Sold in Public Offering shares 4.93M 2021-01-01 2021-01-20 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap PaymentsForOtherOperatingActivities Payments for Other Operating Activities USD 1.03M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap PaymentsForRent Payments for Rent USD 6,750 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 499,997 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 139,749 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 10.52M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1,714 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 244 2019-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 786,731 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 1.11M 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 70,775 2020-06-30 2020 Q2 10-Q 2020-07-30 0001213900-20-019151
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 85,000 2020-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap PrepaidInsurance Prepaid Insurance USD 426,000 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 3.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 30,722 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 69.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ProceedsFromLoanOriginations1 Proceeds from Loan Originations USD 108,500 2020-04-29 2020-05-01 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap ProceedsFromLoans Proceeds from Loans USD 108,500 2020-04-30 2020-05-01 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 169,049 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap ProceedsFromOtherDeposits Proceeds from Other Deposits USD 13,442 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 5.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 887 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 299,788 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 66,710 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -4.12M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20,789 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap PublicUtilitiesApprovedRateIncreaseDecreaseAmount Public Utilities, Approved Rate Increase (Decrease), Amount USD 1.25 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap PurchaseObligation Purchase Obligation USD 2.48M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 12,953 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 103,000 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-07-30 0001213900-20-019151
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 5.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2.24M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001213900-21-014576
us-gaap RestrictedCash Restricted Cash USD 541,180 2023-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030766
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 52.52M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 51.52M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 541,180 2022-12-31 2023 FY 10-K 2024-03-18 0001493152-24-010302
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 1.00M 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.00M 2021-12-31 2022 FY 10-K 2023-03-20 0001493152-23-008241
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 134,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -102.85M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 78,351 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 3.13 2021-03-31 2021 Q1 10-Q 2021-05-03 0001213900-21-024222
us-gaap SecuritiesLoanedFairValueOfCollateral Securities Loaned, Fair Value of Collateral USD 14.20M 2021-06-30 2021 Q2 10-Q 2021-07-29 0001213900-21-039286
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 777,725 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 9,500 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 63,000 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.809 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee shares 468,099 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 11,782 2021-03-01 2021-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 3.35 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 45,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-021927
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 44,524 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 8.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 1,342 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-29 0001213900-20-033954
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 235,570 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.3 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 692,666 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.49M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.35 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 6,000 2023-09-30 2023 Q3 10-Q 2023-11-08 0001493152-23-039896
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 246,000 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 5.97 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001493152-24-044010
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.41 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap SharePrice Share Price USD/shares 1.03 2020-09-30 2021 Q3 10-Q 2021-11-01 0001213900-21-055780
us-gaap SharesIssued Shares, Issued shares 95,779 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.03 2021-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 67,100 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 6,750 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-15 0001493152-26-023740
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 23.23M 2020-06-30 2020 Q2 10-Q 2020-07-30 0001213900-20-019151
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 957 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 2,500 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030766
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 25,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 274 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 52,000 2020-01-01 2020-03-31 2021 Q2 10-Q 2021-07-29 0001213900-21-039286
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 134,100 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.61M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 13,442 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 100,500 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 167,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-01 0001213900-21-055780
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 267,004 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 887 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount USD 961,545 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 3.13 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 2.57M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-07 0001493152-22-030819
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 499,997 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0001641172-25-000926
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 7.00M 2021-11-30 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 353,667 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap TradingSecurities Debt Securities, Trading, and Equity Securities, FV-NI USD 7.11M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013612
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -4,961 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 300,000 2022-03-31 2022 Q1 10-Q 2022-05-03 0001213900-22-023583
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 12.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 10.90M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-10 0001213900-22-011581
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 12.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 70,745 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-17 0001493152-26-052848

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →